Gene · 4923
Papers2,119
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,119
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bradykinin and Neurotensin Analogues as Potential Compounds in Colon Cancer Therapy. | Int J Mol Sci | 2023 | 37298595 | PubTator, text mining | PubMed |
| Targeting IGF2BP3 in Cancer. | Int J Mol Sci | 2023 | 37298373 | PubTator, text mining | PubMed |
| Stabilization of pre-existing neurotensin receptor conformational states by β-arrestin-1 and the biased allosteric modulator ML314. | Nat Commun | 2023 | 37286565 | PubTator, text mining | PubMed |
| Decreased plasma neuropeptides in first-episode schizophrenia, bipolar disorder, major depressive disorder: associations with clinical symptoms and cognitive function. | Front Psychiatry | 2023 | 37275985 | PubTator, text mining | PubMed |
| The Application of Radiolabeled Targeted Molecular Probes for the Diagnosis and Treatment of Prostate Cancer. | Korean J Radiol | 2023 | 37271211 | PubTator, text mining | PubMed |
| Conformational Dynamics of the Activated GLP-1 Receptor-Gs Complex Revealed by Cross-Linking Mass Spectrometry and Integrative Structure Modeling. | ACS Cent Sci | 2023 | 37252352 | PubTator, text mining | PubMed |
| Mechanistic insights into heat shock protein 27, a potential therapeutic target for cardiovascular diseases. | Front Cardiovasc Med | 2023 | 37252119 | PubTator, text mining | PubMed |
| Neurotensin and Alcohol Use Disorders: Towards a Pharmacological Treatment. | Int J Mol Sci | 2023 | 37240004 | PubTator, text mining | PubMed |
| Screening of Membrane Protein Production by Comparison of Transient Expression in Insect and Mammalian Cells. | Biomolecules | 2023 | 37238687 | PubTator, text mining | PubMed |
| Development and validation of a clinical cure marker based on negative lymph nodes for gastric cancer after gastrectomy. | Front Surg | 2023 | 37228762 | PubTator, text mining | PubMed |
| Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R. | Cancers (Basel) | 2023 | 37190273 | PubTator, text mining | PubMed |
| The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions. | Front Oncol | 2023 | 37188192 | PubTator, text mining | PubMed |
| The Membrane Protein Sortilin Is a Potential Biomarker and Target for Glioblastoma. | Cancers (Basel) | 2023 | 37173980 | PubTator, text mining | PubMed |
| Plasma membrane preassociation drives β-arrestin coupling to receptors and activation. | Cell | 2023 | 37146613 | PubTator, text mining | PubMed |
| NMR sample optimization and backbone assignment of a stabilized neurotensin receptor. | J Struct Biol | 2023 | 37142193 | PubTator, text mining | PubMed |
| NTS, NTSR1 and ERs in the Pituitary-Gonadal Axis of Cycling and Postnatal Female Rats after BPA Treatment. | Int J Mol Sci | 2023 | 37108581 | PubTator, text mining | PubMed |
| Evaluating the Feasibility of Pro-Neurotensin and 25-Hydroxyvitamin D3 as Possible Indicators for Type 2 Diabetes Mellitus and Its Complications. | Healthcare (Basel) | 2023 | 37107924 | PubTator, text mining | PubMed |
| Integrative bioinformatics approaches to establish potential prognostic immune-related genes signature and drugs in the non-small cell lung cancer microenvironment. | Front Pharmacol | 2023 | 37077811 | PubTator, text mining | PubMed |
| Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D1 Dopamine Receptor and Their Roles in Modulating β-Arrestin Binding and Activation. | Int J Mol Sci | 2023 | 37047571 | PubTator, text mining | PubMed |
| Neurotensin Gene rs2234762 C>G Variant Associates with Reduced Circulating Pro-NT Levels and Predicts Lower Insulin Resistance in Overweight/Obese Children. | Int J Mol Sci | 2023 | 37047432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4923/papers?page=12